Trials / Sponsors / BGI, China
BGI, China
Academic / Other · 7 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) AML, t(8;21), Neoantigen | EARLY_Phase 1 | 2024-02-01 |
| Recruiting | Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T T-cell Lymphoma | EARLY_Phase 1 | 2023-12-01 |
| Unknown | HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors Solid Tumor | Phase 1 | 2023-04-13 |
| Unknown | Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03) Solid Tumor | Phase 1 | 2023-01-10 |
| Unknown | Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02) Solid Tumor | Phase 1 | 2022-09-28 |
| Unknown | TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor Tumor Gastric, Tumor, Colorectal | N/A | 2017-12-01 |
| Completed | Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes) Solid Cancer | Phase 1 | 2016-12-22 |